Page last updated: 2024-08-17

levodopa and Nervous System Disorders

levodopa has been researched along with Nervous System Disorders in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-199020 (42.55)18.7374
1990's15 (31.91)18.2507
2000's3 (6.38)29.6817
2010's9 (19.15)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bishop, C1
Beck, JP; Bruns, RF; Carter, G; Chernet, E; Eastwood, BJ; Falcone, JF; Hao, J; Harper, AJ; Katner, JS; Li, X; Love, PL; Maren, DL; Masquelin, ME; Menezes, MM; Mitchell, SN; Murray, TK; O'Neill, MJ; Ryder, JW; Schaus, JM; Shanks, EA; Svensson, KA; Thompson, LK; Wafford, KA; Wang, H; Witkin, JM; Yang, CR; Zhang, L1
Martey, J; Rajabally, YA1
Schneemilch, C1
Allen, GF; Clayton, PT; Footitt, EJ; Heales, SJ; Mills, PB; Oppenheim, M1
Chao, OY; Huston, JP; Li, JS; Pum, ME1
Krzyściak, W1
Blau, N; Dill, P; Somerville, A; Thöny, B; Wagner, M; Weber, P1
Barker, RA; Brooks, DJ; Burn, DJ; Coleman, S; Duncan, GW; Khoo, TK; O'Brien, JT; Yarnall, AJ1
Mrowka, M; Odin, P; Shing, M1
Ikemoto, K1
Aubin, N; Barneoud, P; Burnier, P; Caille, D; Carter, C; Charieras, T; Curet, O; Gardes, A; George, P; Jegham, S; Le Kim, A; Lolivier, J; Marc, C; Pandini, M; Perron, C; Puech, F; Scatton, B; Sontag, N1
Iadgarov, IS1
Yung, CY1
Gerber, JC; Grossman, MH; Hare, TA; Katz, L; Manyam, NV1
Caraceni, T; Cocchi, D; Giovannini, P; Martinez-Campos, A; Müller, EE; Parati, EA; Zanardi, P1
Sacks, OW1
Markova, ED; Shmidt, EV; Tkachev, RA2
Calne, DB; Chu, NS; Huang, CC; Lu, CS1
Aronowitz, JS; Gordon, MF; Kane, JM; Lieberman, JA; Pollack, S; Safferman, AZ1
Fiszer, U; Fredrikson, S; Kostulas, V; Link, H; Mix, E; Olsson, T1
Calne, DB; Chu, NS; Hochberg, F; Huang, CC; Lilienfeld, D; Lu, CS; Olanow, W1
Blankson, S; Daniel, SE; Hughes, AJ; Lees, AJ1
Dickson, DW; Duvoisin, RC; Mark, MH; Sage, JI1
Benhadjali, J; Bughin, M; Delalande, I; Destée, A; Forzy, G; Hache, JC1
Albanese, A; Colosimo, C; Lees, AJ; Tonali, P1
Brefel-Courbon, C; Fabre, N; Rascol, O1
Aitken, JW; Fotteler, B; Jorga, KM; Nielsen, T; Sedek, G; Zürcher, G1
Simuni, T; Stern, MB1
Greer, M1
Seyfert, S; Straschill, M1
Bannister, R1
Moskowitz, MA; Wurtman, RJ1
Gerstenbrand, F; Gründig, E; Weiss, J1
Zenkov, LR1
Abroms, IF; Breslow, JL; Brewster, TG; Kaufman, S; Milstien, S; Moskowitz, MA1
Binswanger, U; Keusch, G; Oswald, N1
De Lean, J; Deck, JH1
Kuran, W1
Wagner, GC; Walsh, SL1
Klein, AT; Langford, HG; Montani, M; Subramony, SH1
Black, CK; Schmidt, CJ; Taylor, VL1
Dickey, W; Morrow, JI1
Lungol, VN; Mikhaĭlenko, ET; Veropotvelian, PN; Zavgorodniaia, LI1
Breck, L; Cedarbaum, JM; Kutt, H; McDowell, FH1
Blonder, J; Cohen, BE; Normand, M; Peled, I; Quint, J; Szeinberg, A1

Reviews

10 review(s) available for levodopa and Nervous System Disorders

ArticleYear
Activity of selected aromatic amino acids in biological systems.
    Acta biochimica Polonica, 2011, Volume: 58, Issue:4

    Topics: Biomarkers; Cardiovascular Diseases; Enzyme Activation; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Levodopa; Melanins; Monophenol Monooxygenase; Nervous System Diseases; Oxidative Stress; Renal Insufficiency, Chronic; Serotonin; Tryptophan; Tyrosine

2011
Restless legs syndrome.
    European journal of neurology, 2002, Volume: 9 Suppl 3

    Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Child; Diagnosis, Differential; Dopamine Agonists; Humans; Levodopa; Narcotics; Nervous System Diseases; Neurologic Examination; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders

2002
Significance of human striatal D-neurons: implications in neuropsychiatric functions.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:3

    Topics: Animals; Antiparkinson Agents; Dopa Decarboxylase; Humans; Levodopa; Limbic System; Mental Disorders; Neostriatum; Nervous System Diseases; Neurons

2004
A review of clinical trials of lithium in neurology.
    Pharmacology, biochemistry, and behavior, 1984, Volume: 21 Suppl 1

    Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis

1984
Growth hormone secretion in neurological disorders.
    Advances in biochemical psychopharmacology, 1981, Volume: 28

    Topics: Benserazide; Disease Models, Animal; Dopamine; Growth Hormone; Humans; Huntington Disease; Levodopa; Nervous System Diseases; Parkinson Disease

1981
The use of clozapine in neurologic disorders.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl B

    Topics: Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Humans; Levodopa; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Tremor

1994
Does levodopa accelerate Parkinson's disease?
    Drugs & aging, 1999, Volume: 14, Issue:6

    Topics: Animals; Clinical Trials as Topic; Dopamine; Humans; Levodopa; Nervous System Diseases; Oxidative Stress; Parkinson Disease

1999
Catecholamines and neurologic diseases (second of two parts).
    The New England journal of medicine, 1975, Aug-14, Volume: 293, Issue:7

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Brain Diseases; Catecholamines; Cerebrovascular Disorders; Dopamine; Dysautonomia, Familial; Dystonia Musculorum Deformans; Hepatic Encephalopathy; Homovanillic Acid; Humans; Huntington Disease; Levodopa; Movement Disorders; Multiple Sclerosis; Nervous System Diseases; Parkinson Disease; Phenylketonurias; Seizures; Spinal Cord Injuries; Torticollis; Tourette Syndrome

1975
[Therapeutic use of L-dopa].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1975, Sep-01, Volume: 28, Issue:17

    Topics: Endocrine System Diseases; Humans; Levodopa; Liver Diseases; Nervous System Diseases; Skin Diseases

1975
Drug-induced neurological disorders.
    Progress in neurobiology, 1990, Volume: 34, Issue:4

    Topics: Antihypertensive Agents; Aspirin; Brain Diseases; Dyskinesia, Drug-Induced; Humans; Levodopa; Nervous System Diseases; Neuromuscular Diseases

1990

Trials

6 trial(s) available for levodopa and Nervous System Disorders

ArticleYear
A review of clinical trials of lithium in neurology.
    Pharmacology, biochemistry, and behavior, 1984, Volume: 21 Suppl 1

    Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis

1984
Levodopa failure in chronic manganism.
    Neurology, 1994, Volume: 44, Issue:9

    Topics: Adult; Chronic Disease; Double-Blind Method; Humans; Levodopa; Male; Manganese Poisoning; Middle Aged; Movement Disorders; Nervous System Diseases; Placebos

1994
The clinicopathologic spectrum of Lewy body disease.
    Advances in neurology, 1996, Volume: 69

    Topics: Adolescent; Aged; Antiparkinson Agents; Brain; Dementia; Family; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Nervous System Diseases; Parkinson Disease

1996
Visual evoked potentials and spatiotemporal contrast sensitivity changes in idiopathic Parkinson's disease and multiple system atrophy.
    Advances in neurology, 1996, Volume: 69

    Topics: Aged; Antiparkinson Agents; Atrophy; Contrast Sensitivity; Evoked Potentials, Visual; Female; Humans; Levodopa; Male; Middle Aged; Motion Perception; Movement; Nervous System Diseases; Parkinson Disease; Space Perception; Time Perception; Vision, Monocular

1996
The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism.
    Advances in neurology, 1996, Volume: 69

    Topics: Aged; Antiparkinson Agents; Atrophy; Autonomic Nervous System; Brain; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Nervous System Diseases; Parkinson Disease; Prospective Studies; Retrospective Studies

1996
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly.
    Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:3

    Topics: Administration, Oral; Aged; Analysis of Variance; Antiparkinson Agents; Benzophenones; Catechol O-Methyltransferase Inhibitors; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Erythrocytes; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Nervous System Diseases; Nitrophenols; Tolcapone

1997

Other Studies

32 other study(ies) available for levodopa and Nervous System Disorders

ArticleYear
Neuroinflammation: Fanning the fire of l-dopa-induced dyskinesia.
    Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:12

    Topics: Animals; Antiparkinson Agents; Cytokines; Disease Models, Animal; Dyskinesia, Drug-Induced; Humans; Inflammation; Levodopa; Nervous System Diseases; Tumor Necrosis Factor-alpha

2019
Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders.
    Neuropharmacology, 2018, Volume: 128

    Topics: Animals; Antipsychotic Agents; Blinking; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Isoquinolines; Levodopa; Macaca mulatta; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nervous System Diseases; Prefrontal Cortex; Psychotic Disorders; Receptors, Dopamine D1; Reserpine; Sleep; Wakefulness

2018
Levodopa, vitamins, ageing and the neuropathy of Parkinson's disease.
    Journal of neurology, 2013, Volume: 260, Issue:11

    Topics: Adult; Aged; Aging; Antiparkinson Agents; Cross-Sectional Studies; Female; Folic Acid; Humans; Levodopa; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Vitamin B 12

2013
[General anaesthesia for neurological diseases].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2010, Volume: 45, Issue:5

    Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Autonomic Nervous System; Brain; Bromocriptine; Dopamine Agonists; Humans; Intubation; Levodopa; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Nervous System Diseases; Neurodegenerative Diseases; Neurosurgery; Parkinson Disease; Piperidines; Premedication; Preoperative Care; Propofol; Remifentanil; Selegiline; Stereotaxic Techniques; Syndrome

2010
Pyridoxal 5'-phosphate in cerebrospinal fluid; factors affecting concentration.
    Journal of inherited metabolic disease, 2011, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Biopterins; Child; Child, Preschool; Cysteine; Epilepsy; False Positive Reactions; Female; Free Radicals; Humans; Infant; Infant, Newborn; Levodopa; Male; Metabolism, Inborn Errors; Middle Aged; Nervous System Diseases; Oxygen; Pyridoxal Phosphate; Reference Values; Reproducibility of Results; Sulfites; Tetrahydrofolates

2011
The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle.
    Neuroscience, 2012, Jan-27, Volume: 202

    Topics: Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Functional Laterality; Levodopa; Male; Medial Forebrain Bundle; Nervous System Diseases; Oxidopamine; Parkinson Disease, Secondary; Psychomotor Performance; Rats; Rats, Wistar; Sympatholytics; Walking

2012
Child neurology: paroxysmal stiffening, upward gaze, and hypotonia: hallmarks of sepiapterin reductase deficiency.
    Neurology, 2012, Jan-31, Volume: 78, Issue:5

    Topics: 5-Hydroxytryptophan; Alcohol Oxidoreductases; Behavior; Benserazide; Consanguinity; Developmental Disabilities; Dopamine Agents; Drug Combinations; Eye Movements; Female; Humans; Infant; Levodopa; Movement Disorders; Muscle Hypotonia; Nervous System Diseases; Neurotransmitter Agents; Phenylketonurias; Treatment Outcome

2012
The spectrum of nonmotor symptoms in early Parkinson disease.
    Neurology, 2013, Jan-15, Volume: 80, Issue:3

    Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition; Cohort Studies; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Parkinson Disease; Surveys and Questionnaires

2013
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Interactions; Levodopa; Maze Learning; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Nervous System Diseases; Nitrophenols; Oxazoles; Oxidopamine; Prefrontal Cortex; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin; Stereotyped Behavior; Tolcapone; Tremor; Tyramine

2004
[Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1983, Volume: 83, Issue:12

    Topics: Adult; Aged; Carbidopa; Catecholamines; Drug Combinations; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Muscular Dystrophies; Nervous System Diseases; Neurotic Disorders; Parkinson Disease

1983
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
    Archives of neurology, 1980, Volume: 37, Issue:6

    Topics: Brain Chemistry; Cerebellar Diseases; Creatine Kinase; Dementia; Diet; Encephalitis; Epilepsy; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hypoxia; Levodopa; Multiple Sclerosis; Muscular Dystrophies; Nervous System Diseases; Parkinson Disease; Tissue Preservation

1980
Acquired Tourettism in adult life.
    Advances in neurology, 1982, Volume: 35

    Topics: Adult; Encephalitis; Humans; Levodopa; Middle Aged; Nervous System Diseases; Tourette Syndrome

1982
[Current problems in the diagnosis and treatment of hereditary diseases of the nervous system].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1982, Volume: 82, Issue:3

    Topics: Basal Ganglia Diseases; Catecholamines; Dystonia Musculorum Deformans; Female; Genetic Carrier Screening; Hepatolenticular Degeneration; Humans; Levodopa; Nervous System Diseases; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis

1982
gamma delta+ T cells are increased in patients with Parkinson's disease.
    Journal of the neurological sciences, 1994, Volume: 121, Issue:1

    Topics: Aged; Blood Cells; Cerebrospinal Fluid; Female; Headache; Humans; Levodopa; Male; Middle Aged; Muscle Contraction; Nervous System Diseases; Parkinson Disease; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes

1994
Progression after chronic manganese exposure.
    Neurology, 1993, Volume: 43, Issue:8

    Topics: Adult; Chronic Disease; Follow-Up Studies; Humans; Levodopa; Male; Manganese; Middle Aged; Movement Disorders; Nervous System Diseases; Occupational Exposure; Parkinson Disease, Secondary

1993
A clinicopathologic study of 100 cases of Parkinson's disease.
    Archives of neurology, 1993, Volume: 50, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Movement Disorders; Nervous System Diseases; Parkinson Disease; Survival Analysis

1993
[Parkinson "plus"].
    La Revue du praticien, 1997, May-15, Volume: 47, Issue:10

    Topics: Antiparkinson Agents; Humans; Levodopa; Nervous System Diseases; Parkinson Disease; Sensitivity and Specificity

1997
How to achieve maximum benefit for the patient with Parkinson's disease.
    Geriatrics, 1976, Volume: 31, Issue:4

    Topics: Aged; Amantadine; Carbidopa; Diagnosis, Differential; Histamine H1 Antagonists; Humans; Levodopa; Nervous System Diseases; Occupational Therapy; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Psychotherapy; Trihexyphenidyl

1976
Reversible spastic and pyramidal tract signs in a patient with Parkinson's disease on L-dopa.
    Journal of neurology, 1977, Oct-07, Volume: 216, Issue:3

    Topics: Female; Humans; Levodopa; Middle Aged; Muscle Spasticity; Nervous System Diseases; Parkinson Disease, Secondary; Pyramidal Tracts

1977
Chronic autonomic failure with postural hypotension.
    Lancet (London, England), 1979, Aug-25, Volume: 2, Issue:8139

    Topics: Autonomic Nervous System; Blood Pressure; Bromocriptine; Cardiovascular System; Chronic Disease; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Nerve Degeneration; Nervous System Diseases; Pressoreceptors

1979
[The activity of aminotransferases in serum and cerebrospinal fluid in neurological diseases (author's transl)].
    Wiener klinische Wochenschrift, 1975, Dec-12, Volume: 87, Issue:23

    Topics: Alanine Transaminase; Amyotrophic Lateral Sclerosis; Aspartate Aminotransferases; Craniocerebral Trauma; Friedreich Ataxia; Guanidines; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Nervous System Diseases; Parkinson Disease; Penicillins; Phenylketonurias; Transaminases

1975
[New trends in clinical neurology].
    Sovetskaia meditsina, 1976, Issue:11

    Topics: Brain; Brain Diseases; Cerebral Cortex; Epilepsy; Evoked Potentials; Humans; Levodopa; Motor Neurons; Movement Disorders; Nervous System Diseases; Neurons; Pain; Radiculopathy; Spinal Nerves; Synaptic Transmission

1976
Dihydropteridine reductase deficiency associated with severe neurologic disease and mild hyperphenylalaninemia.
    Pediatrics, 1979, Volume: 63, Issue:1

    Topics: 5-Hydroxytryptophan; Ascorbic Acid; Consanguinity; Dopamine; Humans; Infant; Levodopa; Liver; Male; NADH, NADPH Oxidoreductases; Nervous System Diseases; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Serotonin

1979
[Key problems of clinical neurogenetics].
    Vestnik Akademii meditsinskikh nauk SSSR, 1976, Issue:7

    Topics: Diagnosis, Differential; Drug Evaluation; Genetic Diseases, Inborn; Humans; Levodopa; Nervous System Diseases; Penicillamine; Stereotaxic Techniques; USSR

1976
[Treatment of uremic sympathicopathy with levodopa].
    Schweizerische medizinische Wochenschrift, 1977, Dec-03, Volume: 107, Issue:48

    Topics: Adult; Autonomic Nervous System; Humans; Hypotension; Levodopa; Male; Nervous System Diseases; Posture; Uremia

1977
Shy-Drager syndrome. Neuropathological correlation and response to levodopa therapy.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1976, Volume: 3, Issue:3

    Topics: Brain; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nervous System Diseases; Spinal Cord; Syndrome

1976
Motor impairments after methamphetamine-induced neurotoxicity in the rat.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:2

    Topics: Animals; Avoidance Learning; Disease Models, Animal; Dopamine; Fenfluramine; Levodopa; Male; Methamphetamine; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Serotonin

1992
Case report: autonomic postganglionic denervation--sural nerve and saphenous vein biopsy.
    The American journal of the medical sciences, 1992, Volume: 303, Issue:5

    Topics: Adult; Catecholamines; Denervation; Dopamine; Hormones; Humans; Levodopa; Microscopy, Electron; Nerve Degeneration; Nervous System Diseases; Saphenous Vein; Sural Nerve

1992
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
    European journal of pharmacology, 1991, Oct-02, Volume: 203, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Fenfluramine; Hippocampus; Levodopa; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Nervous System Diseases; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin

1991
[Pathogenesis and correction of disorders of the sympathetic-adrenal and immune systems in abortion].
    Akusherstvo i ginekologiia, 1985, Issue:8

    Topics: Abortion, Threatened; Adrenal Gland Diseases; Adult; Antibody Formation; Female; Humans; Immune System Diseases; Immunity, Cellular; Levodopa; Nervous System Diseases; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Sympathetic Nervous System

1985
Controlled-release levodopa/carbidopa. I. Sinemet CR3 treatment of response fluctuations in Parkinson's disease.
    Neurology, 1987, Volume: 37, Issue:2

    Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Nervous System Diseases; Parkinson Disease

1987
Malignant phenylketonuria due to defective synthesis of dihydrobiopterin.
    Israel journal of medical sciences, 1985, Volume: 21, Issue:6

    Topics: 5-Hydroxytryptophan; Biopterins; Carbidopa; Drug Combinations; Female; Humans; Infant, Newborn; Levodopa; Male; Nervous System Diseases; Phenylalanine; Phenylketonurias; Pteridines; Tyrosine

1985